Endometrial carcinoma (staging)
Updates to Article Attributes
Body
was changed:
Endometrial carcinoma staging allows appropriate treatment options to be considered and enables greater prognostic accuracy for endometrial carcinoma.
Staging
Staging can be based on the TNM or FIGO system. MR
MR imaging is the modality of choice for staging with CT having relatively low specificity (especially for myometrial invasion 5).
FIGO system
Revised 2009 FIGO staging for carcinoma of the endometrium 7
- stage 0: carcinoma in situ
-
stage I: limited to the body of the uterus
- Ia: no or less than half (≤ 50%) myometrial invasion
- Ib: invasion equal to or more than half (≥ 50%) of the myometrium
-
stage II: cervical stromal involvement
- endocervical glandular involvement only is stage I
-
stage III: local or regional spread of the tumour
- IIIa: tumour invades the serosa of the body of the uterus and/or adnexa
- IIIb: vaginal or parametrial involvement
-
IIIc: pelvic or para-aortic lymphadenopathy
- IIIc1: positive pelvic nodes
- IIIc2: positive para-aortic nodes with or without pelvic nodes
-
stage IV: involvement of rectum and or bladder mucosa and or distant metastasis
- IVa: bladder or rectal mucosal involvement
- IVb: distant metastases, malignant ascites, peritoneal involvement
See also
-<p><strong>Endometrial carcinoma staging </strong>allows appropriate treatment options to be considered and enables greater prognostic accuracy for <a href="/articles/endometrial-cancer">endometrial carcinoma</a>. </p><h4>Staging</h4><p>Staging can be based on the <a href="/articles/tnm-staging-system">TNM</a> or <a href="/articles/figo">FIGO</a> system. MR imaging is the modality of choice for staging with CT having relatively low specificity (especially for myometrial invasion <sup>5</sup>).</p><h5>FIGO system</h5><p>Revised 2009 FIGO staging for carcinoma of the endometrium <sup>7</sup></p><ul>- +<p><strong>Endometrial carcinoma staging </strong>allows appropriate treatment options to be considered and enables greater prognostic accuracy for <a href="/articles/endometrial-cancer">endometrial carcinoma</a>. </p><h4>Staging</h4><p>Staging can be based on the <a href="/articles/tnm-staging-system">TNM</a> or <a href="/articles/figo">FIGO</a> system. </p><p>MR imaging is the modality of choice for staging with CT having relatively low specificity (especially for myometrial invasion <sup>5</sup>).</p><h5>FIGO system</h5><p>Revised 2009 FIGO staging for carcinoma of the endometrium <sup>7</sup></p><ul>
References changed:
- 8. Freeman SJ, Aly AM, Kataoka MY et-al. The revised FIGO staging system for uterine malignancies: implications for MR imaging. Radiographics. 2012;32 (6): 1805-27. <a href="http://dx.doi.org/10.1148/rg.326125519">doi:10.1148/rg.326125519</a> - <a href="http://www.ncbi.nlm.nih.gov/pubmed/23065170">Pubmed citation</a><span class="auto"></span>
Unable to process the form. Check for errors and try again.